We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBTM
1451
JBT Marel
JBTM
$6.39B
| $10.1M | ﹤0.01% |
110,554
-4,159
| -4% | -$381K |
|
1452
Blackbaud
BLKB
$2.08B
| $10.1M | ﹤0.01% |
171,460
+33,710
| +24% | +$1.89M |
|
1453
PVH
PVH
$4.04B
| $10.1M | ﹤0.01% |
142,596
-5,647
| -4% | -$337K |
|
1454
Griffon
GFF
$4.86B
| $10M | ﹤0.01% |
280,672
+133,051
| +90% | +$4.44M |
|
1455
Cactus
WHD
$5.44B
| $10M | ﹤0.01% |
199,694
-56,101
| -22% | -$2.81M |
|
1456
Ralph Lauren
RL
$23.6B
| $10M | ﹤0.01% |
94,814
-9,268
| -9% | -$928K |
|
1457
Huntsman Corp
HUN
$1.77B
| $10M | ﹤0.01% |
364,557
-9,710
| -3% | -$264K |
|
1458
Red Rock Resorts
RRR
$3.62B
| $10M | ﹤0.01% |
250,156
-21,357
| -8% | -$877K |
|
1459
Post Holdings
POST
$3.57B
| $10M | ﹤0.01% |
110,782
+290
| +0.3% | +$25.9K |
|
1460
Buckle
BKE
$2.37B
| $9.99M | ﹤0.01% |
220,391
+106,281
| +93% | +$4.29M |
|
1461
Abercrombie & Fitch
ANF
$5B
| $9.99M | ﹤0.01% |
436,168
+255,045
| +141% | +$5.02M |
|
|
HTBK
1462
DELISTED
Heritage Commerce
HTBK
| $9.98M | ﹤0.01% |
767,875
+36,276
| +5% | +$488K |
|
1463
Sally Beauty Holdings
SBH
$1.58B
| $9.98M | ﹤0.01% |
797,031
+362,636
| +83% | +$4.45M |
|
1464
Onto Innovation
ONTO
$15.3B
| $9.96M | ﹤0.01% |
172,463
+26,157
| +18% | +$1.88M |
|
|
DVAX
1465
DELISTED
Dynavax Technologies
DVAX
| $9.94M | ﹤0.01% |
933,787
-489,446
| -34% | -$5.69M |
|
|
ABCM
1466
DELISTED
Abcam PLC
ABCM
| $9.93M | ﹤0.01% |
+637,900
| New | +$9.96M |
|
1467
Trustmark
TRMK
$2.75B
| $9.93M | ﹤0.01% |
284,285
+29,835
| +12% | +$1.04M |
|
1468
GlobalFoundries
GFS
$29.6B
| $9.92M | ﹤0.01% |
184,040
+17,323
| +10% | +$1.01M |
|
1469
SL Green Realty
SLG
$3.99B
| $9.9M | ﹤0.01% |
293,516
-478,647
| -62% | -$18.2M |
|
1470
Unifirst Corp
UNF
$5.25B
| $9.89M | ﹤0.01% |
51,268
-2,101
| -4% | -$384K |
|
1471
STAAR Surgical
STAA
$1.21B
| $9.87M | ﹤0.01% |
203,419
-20,146
| -9% | -$1.26M |
|
|
ICPT
1472
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.87M | ﹤0.01% |
797,910
+385,884
| +94% | +$5.46M |
|
1473
International Money Express
IMXI
$367M
| $9.87M | ﹤0.01% |
404,849
-38,350
| -9% | -$881K |
|
1474
Rocket Pharmaceuticals
RCKT
$394M
| $9.86M | ﹤0.01% |
503,721
+271,332
| +117% | +$5M |
|
1475
Rapid7
RPD
$773M
| $9.86M | ﹤0.01% |
290,074
-5,616
| -2% | -$201K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.